Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
Stephen A Harrison, MD, Juan P Frias, MD, et al, for the HARMONY Study Group Lancet Gastroenterol Hepatol 2023, DOI:https://doi.org/10.1016/S2468-1253(23)00272-8 Πατώντας ΕΔΩ μπορείτε να δείτε